Announcements Trials
Browse Landscape

Status

Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 41INDUSTRY 3OTHER_GOV 2

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Neoplasms 2Prostatic Neoplasms 1Pancreatic cancer, adult 1Ovarian Neoplasms 1Lung Neoplasms 1Glioblastoma 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Blood Specimen Collection 31Sorafenib 29Nivolumab 29Bevacizumab 26Data Collection 24Observation 23palbociclib 22Sunitinib 22radium Ra 223 dichloride 20enzalutamide 18Rituximab 18Ipilimumab 16regorafenib 15Drug Therapy 15Trastuzumab 14Docetaxel 14ribociclib 12exemestane 12atezolizumab 12Standard of Care 12darolutamide 11apalutamide 11Leuprolide 11Capecitabine 11Afatinib 11Bortezomib 10Anastrozole 10trastuzumab deruxtecan 9pembrolizumab 9avelumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Hematologic Tests × Clear all
NCT06717295 2026-01-02

CCANED-CIPHER

Dysplasia Diagnostics Limited

Recruiting
6,000 enrolled
CNSGastrointestinalGenitourinaryGynecologicThoracic

Pancreatic cancer, adult, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Carcinoma, Hepatocellular, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT05370300 2024-03-06

SNAPS Breast Cancer Patient Study Breast Cancer Patients

Immunis.AI

Not yet recruiting
500 enrolled
Breast

Breast Neoplasms

NCT02288754 2019-08-14

Detection of Tumor DNA in Blood Samples From Cancer Patients

Lexent Bio, Inc.

Unknown
500 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡